Medical Program: Getting Ahead of Recurrence in Non-Small Cell Lung Cancer

Getting Ahead of Recurrence in NSCLC

Getting Ahead of Recurrence in NSCLC

Recurrence is unfortunately all too common in non-small cell lung cancer patients, but there are ways to catch—and treat—recurrent disease early on.

  • Overview

    Even in early-stage disease, the recurrence rate for non-small cell lung cancer can be as high as 30 to 50 percent. Hear from oncologist Dr. Christine Bestvina on how she manages patients with recurrent disease.

    Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.

Facebook Comments



We’re glad to see you’re enjoying Global Oncology Academy…
but how about a more personalized experience?

Register for free